Ordering Recommendation

Use to detect and differentiate dengue subtypes 1-4.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Lavender (EDTA), Pink (K2EDTA), or Serum Separator Tube (SST).

Specimen Preparation

Separate serum or plasma from cells. Transfer 1 mL serum or plasma to a sterile container. (Min: 0.5mL)

Storage/Transport Temperature

Frozen

Unacceptable Conditions

Heparinized specimens.

Remarks

Specimen source required.

Stability

Ambient: 24 hours; Refrigerated: 5 days; Frozen: 2 weeks

Methodology

Qualitative Polymerase Chain Reaction

Performed

Tue, Fri

Reported

2-5 days

Reference Interval

Interpretive Data

A negative result does not rule out the presence of PCR inhibitors in the patient specimen or of test-specific nucleic acid in concentrations below the level of detection by this test.

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Compliance Category

Laboratory Developed Test (LDT)

Note

This assay detects and differentiates Dengue subtypes 1-4.

Hotline History

N/A

CPT Codes

87798 x4

Components

Component Test Code* Component Chart Name LOINC
2013295 Dengue by PCR, Source 31208-2
2013296 Dengue Type 1 by PCR 60262-3
2013297 Dengue Type 2 by PCR 60420-7
2013298 Dengue Type 3 by PCR 60419-9
2013299 Dengue Type 4 by PCR 60418-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • Breakbone Fever
Dengue Virus (1-4) Subtype by PCR